Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group, Peter W Horby, Guilherme Pessoa-Amorim, Natalie Staplin, Jonathan R Emberson, Mark Campbell, Enti Spata, Leon Peto, Nigel J Brunskill, Simon Tiberi, Victor Chew, Thomas Brown, Hasan Tahir, Beate Ebert, David Chadwick, Tony Whitehouse, Rahuldeb Sarkar, Clive Graham, J Kenneth Baillie, Buddha Basnyat, Maya H Buch, Lucy C Chappell, Jeremy Day, Saul N Faust, Raph L Hamers, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray
doi: https://doi.org/10.1101/2021.06.08.21258132

Article Information

doi 
https://doi.org/10.1101/2021.06.08.21258132
History 
  • June 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. RECOVERY Collaborative Group*,
  2. Peter W Horby1,*,‡&,
  3. Guilherme Pessoa-Amorim2,*,‡,
  4. Natalie Staplin3,‡,†,
  5. Jonathan R Emberson3,
  6. Mark Campbell2,
  7. Enti Spata3,
  8. Leon Peto2,
  9. Nigel J Brunskill4,
  10. Simon Tiberi5,
  11. Victor Chew6,
  12. Thomas Brown7,
  13. Hasan Tahir8,
  14. Beate Ebert9,
  15. David Chadwick10,
  16. Tony Whitehouse11,
  17. Rahuldeb Sarkar12,
  18. Clive Graham13,
  19. J Kenneth Baillie14,
  20. Buddha Basnyat15,
  21. Maya H Buch16,
  22. Lucy C Chappell17,
  23. Jeremy Day18,
  24. Saul N Faust19,
  25. Raph L Hamers20,
  26. Thomas Jaki21,
  27. Edmund Juszczak23,
  28. Katie Jeffery22,
  29. Wei Shen Lim24,
  30. Alan Montgomery23,
  31. Andrew Mumford25,
  32. Kathryn Rowan26,
  33. Guy Thwaites18,
  34. Marion Mafham2,+,
  35. Richard Haynes3,+ and
  36. Martin J Landray2,+
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;
  2. 2Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom;
  3. 3MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom;
  4. 4University of Leicester, Leicester, United Kingdom;
  5. 5Barts Health NHS Foundation Trust, London, United Kingdom;
  6. 6North Tees and Hartlepool NHS Foundation Trust, Hartlepool, United Kingdom;
  7. 7Portsmouth Hospitals University NHS Foundation Trust, Portsmouth, United Kingdom;
  8. 8Royal Free London NHS Foundation Trust, London, United Kingdom;
  9. 9North West Anglia NHS Foundation Trust, Peterborough, United Kingdom;
  10. 10James Cook University Hospital, Middlesbrough, United Kingdom;
  11. 11University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;
  12. 12Medway NHS Foundation Trust, Gillingham, UK;
  13. 13North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK;
  14. 14Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom;
  15. 15Oxford University Clinical Research Unit, Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal;
  16. 16Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom;
  17. 17School of Life Sciences, Kings College London, London, United Kingdom;
  18. 18Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, and Nuffield Department of Medicine, University of Oxford, United Kingdom;
  19. 19NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom;
  20. 20Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia and Faculty of Medicine, University of Indonesia, Jakarta, Indonesia, and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingd;
  21. 21Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom;
  22. 22Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
  23. 23School of Medicine, University of Nottingham, Nottingham, United Kingdom;
  24. 24Respiratory Medicine Department, Nottingham University Hospitals NHS Foundation Trust, Nottingham, United Kingdom;
  25. 25School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom;
  26. 26Intensive Care National Audit and Research Centre, London, United Kingdom
  1. ↵&Correspondence to: Prof Peter W Horby and Prof Martin J Landray, RECOVERY Central Coordinating Office, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom., Email: recoverytrial{at}ndph.ox.ac.uk

  1. ↵‡ PWH, GPA and NS made an equal contribution

  2. ↵+ MM, RH and MJL made an equal contribution

Back to top
Posted June 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Peter W Horby, Guilherme Pessoa-Amorim, Natalie Staplin, Jonathan R Emberson, Mark Campbell, Enti Spata, Leon Peto, Nigel J Brunskill, Simon Tiberi, Victor Chew, Thomas Brown, Hasan Tahir, Beate Ebert, David Chadwick, Tony Whitehouse, Rahuldeb Sarkar, Clive Graham, J Kenneth Baillie, Buddha Basnyat, Maya H Buch, Lucy C Chappell, Jeremy Day, Saul N Faust, Raph L Hamers, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray
medRxiv 2021.06.08.21258132; doi: https://doi.org/10.1101/2021.06.08.21258132
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area